MENU
SGMT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Sagimet Biosciences (SGMT) Earnings Date & Reports

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways... Show more

A.I. Advisor
published Earnings

SGMT is expected to report earnings to rise 57.14% to -87 cents per share on August 25

Sagimet Biosciences SGMT Stock Earnings Reports
Q2'25
Est.
$-0.88
Q1'25
Beat
by $0.15
Q4'24
Missed
by $0.01
Q3'24
Beat
by $0.10
Q2'24
Beat
by $0.25
The last earnings report on May 08 showed earnings per share of -56 cents, beating the estimate of -70 cents. With 417.42K shares outstanding, the current market capitalization sits at 291.37M.
View a ticker or compare two or three
SGMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SGMT showed earnings on May 08, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
155 Bovet Road
Phone
+1 650 561-8600
Employees
10
Web
https://www.sagimet.com